Uri Yaron

Uri is a HealthTech and Life Sciences investment Executive who serves on multiple Boards. In his previous role he served as the WW President of Biosense Webster (BWI), a member of the Johnson & Johnson Family of Companies. Uri joined BWI in 1996, a year prior to its acquisition by J&J. Prior to his WW President role, Uri has held several positions of increasing responsibilities in R&D, Business Development and General Management at Biosense Webster, Cordis, Cerenovus, Mentor, Acclarent, ASP & Sterilmed.

Uri is known as a strategic leader who established outstanding relationships with both customers and external partners, creating significant value for J&J in the Cardiovascular space. He has a proven track record of driving innovation and growth and adapting the company’s business model to a rapidly changing and increasingly challenging external environment. Under Uri’s Leadership, BWI teams have won 5 Johnson Medals, the most prestigious award given for research & development excellence within J&J.

Uri holds a PhD in Physics from the Hebrew University of Jerusalem, summa cum laude. Prior to joining BWI, Uri was a Member of the Technical Staff at the Micro-Physics Research Lab of AT&T Bell Laboratories. He is a co-author of over 40 peer-reviewed papers, including papers in Nature and Physical Review Letters, and the co-inventor of over 10 US patents.

Uri serves on the Board of Directors of the Western States of the American Heart Association. He was the Chairperson of the 2020 LA Heart & Stroke Walk. In addition, Uri teaches an MBA course at the BioMed MBA Program of the Hebrew University, and coaches senior combat officers of the Israeli Defense Forces.